Clinical Features and Management of Cystine Nephrolithiasis

  • L. Miano
  • I. Antonozzi
  • M. Gallucci
  • S. Morano
  • S. Petta
Part of the Ettore Majorana International Science Series book series (EMISS, volume 9)


The Authors report the clinical features of cystine nephrolithiasis in 57 patients with cystinuria observed from 1972 to 1980. The disease affects both sexes with equal frequency and severity. Symptom usually begin early, mostly between 15 and 20 years, but may develop at any age. Treatment consists of the administration of adequate oral fluids to obtain a copious urine volume, of oral alkali and of α-mercaptopropionylglycine. Successful results, from litholytic and from preventive medical treatment, were obtained in a high percentage of cases.


Calcium Oxalate Urinary Infection Idiopathic Hypercalciuria Stone Passage Cystine Stone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bartter, F.C., Lötz, M. and Thier, S.O.: Cystinuria. Ann, Int. Med. 62: 796–822, (1965).Google Scholar
  2. 2.
    Caldwell, R.J., Townsend, J.I. and Smith, M.J.V.: Genetics of cystinuria in an inbred population. J. Urol. 119: 531–533, (1978).Google Scholar
  3. 3.
    Dahlberg, P.J., Van der Berg, C.J., Kurtz, S.B., Wilson, D.M. and Smith, L.H.: Clinical features and management of cystinuria. Mayo Clinic. Proc. 52: 533–542, (1977).Google Scholar
  4. 4.
    Dent, C.E. and Senior, B.: Studies in the treatment of cystinuria. Brit. J. Urol. 27: 317–332, (1955).CrossRefGoogle Scholar
  5. 5.
    Kallistratos, G., Burchardt, P. and Freerksent, P.: Recent advances in the diagnosis and treatment of L-cystine stone disease. Folia Bioch. Biol. Graeca 15: 21–23, (1978).Google Scholar
  6. 6.
    King, J.S. Jr.: Treatment of cystinuria with öC-mercaptopropionylglycine. Proc. Soc. Exp. Biol. Med, 199: 927–932, (1969),Google Scholar
  7. 7.
    Kinoschita, K., Yachiku, S., Takeuki, N., Kotake, T., and Sonoda, T.: Treatment of cystinuria with (X-mercaptopropio- nylglycine. Proc. 2nd int. Symp. on Thiola, pp. 50–54 Santen, Osaka, (1972).Google Scholar
  8. 8.
    Hautmann, R., Terhost, B., Stuhlsatz, H.W. and Lutzeyer, W.: Mercaptopropionylglycine: a progress in cystine stone therapy. J. Urol. 117: 628–630, (1977).Google Scholar
  9. 9.
    Lötz, M., Potts, J.T. Jr. and Holland, J.M.: D-penicillamine therapy in cystinuria. J. Urol, 95: 257–263, (1966).Google Scholar
  10. 10.
    Miano, L.: Cistinuria e litiasi cistinica. Progr, Med. 28: 285–287, (1972).Google Scholar
  11. 11.
    Miano, L., Gallucci, M. and Petta, S.: Results of medical treatment of cystine lithiasis. Eur. Urol. 5: 265–272, (1979).Google Scholar
  12. 12.
    Remieen, A., Kallistratos, G. and Burchardt, P.: Treatment of cystinuria with Thiola (α.-mercaptopropionylglycine). Eur. Urol. 1: 227–230, (1975).Google Scholar
  13. 13.
    Rosenberg, L.E., Downing, S. and Durant, J.L.: Cystinuria: biochemical evidence for three genetically distinct diseases. J. Clin. Invest. 45: 365–371, (1966).CrossRefGoogle Scholar
  14. 14.
    Silbernagl, S.: Renal handling of aminoacids: recent results of tubular microperfusion. Clin. Nephrol. 5: 1–8, (1976).Google Scholar
  15. 15.
    Terhorst, B. and Stuhlsatz, H.W.: Cysteine Therapie mit Mercaptopropionylglycine (MPG). Urologe 14: 190–193, (1975).Google Scholar
  16. 16.
    Thier, S.O. and Segal, S.: Cystinuria in “The metabolic basis of inherited disease” edited by Stanbury J.B., Wyngaarden J.B., Fredrickson D.S., pp. 1504–1519 Mc Graw-Hill Book Comp., New York, (1972).Google Scholar
  17. 17.
    Zechner, O., Latal, D., Grundig, E. and Muller, M.: Klinische Aspekte der Cystinuria und ihre Behandlung mit Thiola. Wien. Klin. Wschr. 88: 101–105, (1976).Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • L. Miano
    • 1
  • I. Antonozzi
    • 2
  • M. Gallucci
    • 1
  • S. Morano
    • 2
  • S. Petta
    • 1
    • 2
  1. 1.Department of UrologyUniversity of RomeItaly
  2. 2.Laboratory of dysmetabolic oligophreni sUniversity of RomeItaly

Personalised recommendations